IPO registrations (S-1, F-1) · Registrants
Q Therapeutics, Inc.
- SEC CIK
- 1366541 · filings on EDGAR ↗
- Former names
- Q Holdings, Inc. (2011–2012); Grace 2, Inc. (2006–2011)
- Registration
- Form S-1, first filed 2012-06-29, last 2014-06-04; 2 initial registrations, 3 amendments
- Outcome
- Declared effective 2012-07-17; withdrawal requested 2012-08-16
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 615 ARAPEEN DRIVE, SUITE 102, Salt Lake City, UT 84108
- EIN
- 20-3708500
- EDGAR entity type
- operating
- Insiders and CEO pay
- Q Therapeutics, Inc. on the corporate pages
On this site
- Form 5500 plan sponsor: Q THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Lobbying client: Q THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: Grace 2, Inc. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-06-29 | S-1 | S-1 (registration) | Q Holdings, Inc. | 0001493152-12-000696 ↗ |
| 2012-07-17 | EFFECT | EFFECT (declared effective) | Q Holdings, Inc. | 9999999995-12-002189 ↗ |
| 2012-08-15 | S-1/A | S-1/A (amendment) | Q Holdings, Inc. | 0001493152-12-001011 ↗ |
| 2012-08-16 | RW | RW (withdrawal request) | Q Holdings, Inc. | 0001493152-12-001018 ↗ |
| 2012-08-27 | EFFECT | EFFECT (declared effective) | Q Holdings, Inc. | 9999999995-12-002591 ↗ |
| 2013-06-20 | S-1 | S-1 (registration) | Q Therapeutics, Inc. | 0001193125-13-265928 ↗ |
| 2013-07-05 | S-1/A | S-1/A (amendment) | Q Therapeutics, Inc. | 0001193125-13-283903 ↗ |
| 2014-06-04 | S-1/A | S-1/A (amendment) | Q Therapeutics, Inc. | 0001193125-14-225833 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-07-05 | S-1/A | registration statement | 5,000,000 | - | OTC QCEL | 0 | primary document; shares headline | document ↗ | ||
| 2014-06-04 | S-1/A | registration statement | - | - | Nasdaq QCEL | 0 | primary document; no terms found | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Sourlis Virginia Kali | Director,Officer,TenPercentOwner; Other | President | 2 | 2006–2008 | |
| BRENNAN JAMES H III | TenPercentOwner | 1 | 2008 | ||
| DYER DOUGLAS A | TenPercentOwner | 1 | 2008 | ||
| BORST STEVEN JOHN | Director,Officer; Officer | CFO & VP of Corp. Development; Chief Executive Officer; Chief Financial Officer | 8 | 2011–2016 | |
| EPPSTEIN DEBORAH ANNE | Director; Director,Officer; Officer | CEO & President, Director; Chief Executive Officer | 6 | 2011–2016 | |
| GOSWAMI JOYDEEP | Director | 2 | 2011–2012 | ||
| HUTT PETER BARTON | Director | 5 | 2011–2014 | ||
| PATEL DINESH C | Director | 3 | 2011–2014 | ||
| GREBOW PETER E | Director | 5 | 2011–2014 | ||
| Q Holdings, Inc. | Officer | Chief Financial Officer | 1 | 2012 | |
| Jorkasky Diane | Director | 2 | 2014 | ||
| JACKSON HUNTER | Director | 2 | 2014 | ||
| Rao Mahendra S. | Officer | Chief Strategy Officer | 2 | 2014 | |
| Green David A | Officer | Chief Financial Officer | 1 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | Q THERAPEUTICS, INC. | UT | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | Q THERAPEUTICS, INC. | UT | Form 5500 (employee benefit plans) | name and state |
| Lobbying client | Q THERAPEUTICS, INC. | UT | Federal lobbying (LDA) | name and state |
| Patent assignee | Q THERAPEUTICS, INC. | UT | Patents (USPTO) | name and state |
| SEC filer | Q Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Q Therapeutics, Inc. | UT | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | Q THERAPEUTICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, UT first:
- ZARS Pharma, Inc. UT
- SANGUI BIOTECH INTERNATIONAL INC UT
- SignPath Pharma, Inc. UT
- THAT MARKETING SOLUTION, INC. UT
- REST EZ Inc. UT
- Clene Inc. UT
- ANESTA CORP /DE/ UT
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
In other datasets, the same topic (Health) in UT:
- Nonprofit: 19 HOPE AND HEALING (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health